BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 28902736)

  • 1. Incidental 131I Activity in the Deltoid Region on Posttherapy Radioiodine Scan.
    Strober MD; Callahan BR
    Clin Nucl Med; 2017 Nov; 42(11):899-900. PubMed ID: 28902736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radioiodine therapy for thyroid cancer depicted uterine leiomyoma.
    Hirata K; Shiga T; Kubota KC; Okamoto S; Kamibayashi T; Tamaki N
    Clin Nucl Med; 2009 Mar; 34(3):180-1. PubMed ID: 19352287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidental Gallbladder Cancer Visualized From Posttreatment 131I Whole-Body Scan.
    Anongpornjossakul Y; Utamakul C; Chamroonrat W; Kositwattanarerk A; Thamnirat K; Sritara C
    Clin Nucl Med; 2016 Mar; 41(3):e162-3. PubMed ID: 26447377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidental finding of hiatal hernia on (99m)Tc-sestamibi whole-body scan in thyroid cancer evaluation.
    Del Castillo-Matos R; Quirce R; Martínez-Rodríguez I; Medina-Quiroz P; Rubio-Vassallo A; Carril JM
    Rev Esp Med Nucl Imagen Mol; 2012; 31(3):163-4. PubMed ID: 22056002
    [No Abstract]   [Full Text] [Related]  

  • 5. A Clear Cell Variant of Papillary Thyroid Microcarcinoma With Lung, Bone, and Soft Tissue Metastases.
    Yazici B; Ertan Y; Oral A; Akgün A
    Clin Nucl Med; 2015 Nov; 40(11):885-7. PubMed ID: 26018685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. False-Positive Radioiodine Uptake From an Intracranial Surgical Clip.
    Walsh JP; Sims JB; Iranpour P
    Clin Nucl Med; 2022 Mar; 47(3):e279-e280. PubMed ID: 35025781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical outcomes and prognostic factors of radioiodine ablation therapy for lymph node metastases from papillary thyroid carcinoma.
    Wu X; Gu H; Gao Y; Li B; Fan R
    Nucl Med Commun; 2018 Jan; 39(1):22-27. PubMed ID: 29135721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radioiodine therapy for differentiated thyroid carcinoma.
    Connor CS; Thomas JH; Robinson RG; Preston DF; Hermreck AS
    Am J Surg; 1988 Dec; 156(6):519-21. PubMed ID: 3202264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Unusual False-Positive Uptake of Radioiodine in Pericardial Effusion on Posttherapy Scan.
    Malhotra G; Moghe SH; Ranade R; Asopa RR
    Clin Nucl Med; 2016 Jul; 41(7):568-9. PubMed ID: 27055143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thallium-201 scintigraphy to predict therapeutic outcome of iodine-131 therapy of metastatic thyroid carcinoma.
    Nakada K; Katoh C; Kanegae K; Tsukamoto E; Shiga T; Mochizuki T; Itoh K; Tamaki N
    J Nucl Med; 1998 May; 39(5):807-10. PubMed ID: 9591580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are posttherapy radioiodine scans informative and do they influence subsequent therapy of patients with differentiated thyroid cancer?
    Fatourechi V; Hay ID; Mullan BP; Wiseman GA; Eghbali-Fatourechi GZ; Thorson LM; Gorman CA
    Thyroid; 2000 Jul; 10(7):573-7. PubMed ID: 10958309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidental thyroid 99mTc-MDP uptake in a patient affected by differentiated thyroid cancer.
    Albano D; Magri GC; Treglia G; Bertagna F
    Nucl Med Rev Cent East Eur; 2016; 19(B):8-10. PubMed ID: 27813621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor thrombus in the great veins from papillary carcinoma of the thyroid: 131I scan findings.
    Mugunthan N; Kumar AR; Thomas P
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2527-8. PubMed ID: 20525903
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thymic uptake of 18FFDG following radioiodine ablation therapy].
    Albalá González MD; Martínez Gimeno E; Cárdenas Negro C; Allende Riera A; Cabello García D; De Sequera Rahola M; Uña Gorospe JA
    Rev Esp Med Nucl; 2011; 30(5):314-6. PubMed ID: 21342725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unusual radioiodine uptake caused by metallic sutures in the skull in a patient with thyroid cancer.
    Modoni S; Martino G; Guerra M; Frusciante V
    Clin Nucl Med; 2000 Dec; 25(12):1053-4. PubMed ID: 11129153
    [No Abstract]   [Full Text] [Related]  

  • 16. Quantitative radioiodine therapy in the treatment of differentiated thyroid cancer.
    Maxon HR
    Q J Nucl Med; 1999 Dec; 43(4):313-23. PubMed ID: 10731782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased 131I accumulation in the polyacrylamide hydrophilic gel used for breast augmentation.
    Lv J; Qu Y; Zhang M; Pan Y; Zhang Y
    Clin Nucl Med; 2014 Apr; 39(4):415-6. PubMed ID: 24566417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
    Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
    Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
    [No Abstract]   [Full Text] [Related]  

  • 19. A proposition for the use of radioiodine in WDTC management.
    Bourgeois P
    J Nucl Med; 2009 Feb; 50(2):328-9; author reply 329-30. PubMed ID: 19164221
    [No Abstract]   [Full Text] [Related]  

  • 20. Visualization of the thymus with therapeutic doses of radioiodine in patients with thyroid cancer.
    Michigishi T; Mizukami Y; Shuke N; Yokoyama K; Noguchi M; Watanabe Y; Matsui O; Aburano T; Tonami N; Hisada K
    Eur J Nucl Med; 1993 Jan; 20(1):75-9. PubMed ID: 8267685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.